The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the “point of no return.” ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

ingested revealed an occasional anthrax bacillus on the smear ... in-vitro sensitivities of the infecting strains of B. anthracis to the antibiotic agents employed. Ingestion of aureomycin ...

The threat of bioterrorism has renewed interest in techniques for pathogen detection, monitoring and analysis. In the May 8 ScienceXpress, Timothy Read and researchers at The Institute for Genome ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a ...

a joint venture of Pitt and UPMC Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the ...